FDA Investigator Gale E Ryan
Gale E Ryan has inspections in 8 countries as of 20 Nov 2023. Gale E Ryan has collaborated with a combinined 2979 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
159
Last Inspection Date:
20 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
United Kingdom of Great Britain and Northern Ireland,
China,
Taiwan,
Switzerland,
Germany,
Italy
Co-Investigator(s):
Aaron L Morris,
Akbar J Zaidi,
Alberto A Viciedo,
Alice C Silva,
Alois P Provost,
Althea A Williams,
Alysia M Salonia,
Amanda T Zick,
Amy M Cramer,
Anabel Veiga,
Anne E Carpenter,
Anthony C Warchut,
Anthony N Onianwa,
Anthony W Thomas,
Arthur S Williams, Jr,
Ashar P Parikh,
Barbara J Rincon,
Barbara M Frazier,
Benjamin J Dastoli,
Bill Tacket, Jr,
Bradford L Swanson,
Brandon J Brookens,
Brenna L Macdowell,
Brian M Carril,
Bruce H Mccullough,
Carla A Norris,
Carol L Rehkopf,
Carr,
CDR Sean T Creighton,
Christopher J Cruciotti,
Christopher K Vantwuyver,
Christopher M Elliott,
Christopher T Smith,
Clara E Santiago,
Clausnitzer,
Clotia Cabbey Mensah,
Cullen T Wilson,
David P King,
David Perkins,
Dawn M Mccabe,
Diane C Thibodeau,
Dianiris C Ayala,
Diantha M Bleau,
Dominic R Frasca,
Donna Mwilliams Hill,
Douglas S Joslin,
Eduardo Carbonell,
Eduardo L Rodriguez,
Edward D Mcdonald,
Edward J Janik,
Edwards,
Edwin J Gorney,
Emily J Schramm,
Eric C Schmitt,
Eric R Holm,
Erin P Conlin,
Frank J Koch,
Gabriel E Muniz,
Gena M Mckahan,
Gerard D Difiore,
German Rivera,
Hunt,
Jacqueline S Warner,
James K Mcnally,
James To Neal,
James W Whitney,
Janete F Guardia,
Janis S Gallagher,
Jason A Rossi,
Jason D Tenney,
Jeffery A Hangartner,
Jeffrey J Thibodeau,
Jeffrey S Buckser,
Jennifer M Menendez,
Joan A Loreng,
Joel R Merriman,
John A Hollings,
John J Bernal,
John J Thibodeau,
John R Carlson,
Jonathan B Lewis,
Jose Alopez Rubet,
Joseph H Procopio,
Joshua J Silvestri,
Joyce A Kellett,
Juanita Banuelos,
Karen E D'orazio,
Karen M Rodriguez,
Katarzyna Plona,
Kellia N Hicks,
Kelly M Byers,
Kevin A Gonzales,
Kevin A Gonzalez,
Kimberly M White,
Kristen D Evans,
Lauren M Lawrance,
Lauren M Mclaughlin,
Laurie B Frazier,
Linda K Matheny,
Linda L Green,
Lirissia Mccoy,
Lisa M Lopez,
Lissette Paiz,
Liz M Otero,
Louis Christy,
LT Richard A Lyght,
Lyndsay M Perryman,
M Patriciaurphy Murphy,
Marc Balzarini,
Marcus F Yambot,
Mark R Mcclain,
Mary F Bodick,
Matthew B Casale,
Maxim,
Maya M Davis,
Meisha A Mandal,
Meyer J Slobotsky,
Michael C Lombardi,
Michael F Mccoy,
Michael G Mayfield,
Michael J Nerz,
Mikayla K Deardorff,
Mra Mcculloughj,
Niketa Patel,
Norman Wong,
Ormond,
Osama A Khatib,
Paige E Shelborne,
Paul M Kawamoto,
Pauline N Logan,
Rachel A Gomez,
Rebecca A Coleman,
Rebecca B Welch,
Rebecca C Maxim,
Reynolds,
Richard G Fochesato,
Richard H Penta,
Richard K Vogel,
Robert D Ogan,
Robert E Hatch,
Robert E Teel,
Robert G Antonsen, Jr,
Roger F Zabinski,
Rupa Pradhan,
Russell J Glapion,
Sally Gopaul,
Sarah Forney,
Sargum C Sood,
Shawn M Bogdan,
Simone E Pitts,
Simone Pins,
Souza,
Stacie A Woods,
Stanley B Eugene, BS, BME,
State Agency,
Stephen C Smith,
Stephen D Eich,
Stephen R Souza,
Steven B Hertz,
Stuart A Feldman,
Susan M Jackson,
Susant Hadman,
Suwaskie S Smith,
Teddy Tom,
Teresa I Navas,
Thomas Cote,
Thomas H Jenkins,
Thomas Siebertz,
Todd D Alspach,
Troy R Petrillo,
Victor Spanioli,
Wendy A Johnecheck,
William K Dagley,
Xiaojun Yan,
Yehualashet A Gessesse
Gale E Ryan's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| August, 2004 | FDA 483 | Sekisui Diagnostics, LLC - Form 483, 2004-08-10 |
| April, 2008 | FDA 483 | Rossmax International Ltd. - Form 483, 2007-10-25 |
| November, 2007 | FDA 483 | Rossmax (Shanghai) Inc., Ltd. - Form 483, 2007-11-01 |
| March, 2008 | FDA 483 | Boston Scientific Corporation - Form 483, 2008-03-20 |
| April, 2008 | EIR | Rossmax International Ltd. - EIR, 2007-10-25 |
| August, 2001 | EIR | BlueTriton Brands, Inc. - EIR, 2001-08-16 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more